Steven Mintz - 01 Apr 2024 Form 4 Insider Report for AgeX Therapeutics, Inc. (SER)

Role
Director
Signature
/s/ STEVEN MINTZ
Issuer symbol
SER
Transactions as of
01 Apr 2024
Net transactions value
$0
Form type
4
Filing time
03 Apr 2024, 20:59:05 UTC
Previous filing
18 Jan 2024
Next filing
23 May 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SER Stock Option (right to buy) Award $0 +40,000 +2208% $0.000000 41,812 01 Apr 2024 Common Stock 40,000 $11.83 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest in three equal installments on April 1, 2025, April 1, 2026 and April 1, 2027, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.
F2 Number of derivative securities determined after giving effect to a reverse split of the Issuer's common stock of 1-for-35.17.